Monoclonal gammopathy of undetermined significant (MGUS), smouldering multiple myeloma (SMM) and active multiple myeloma are a group of conditions and diseases that fall under the category of plasma cell disorders. As the name suggests, plasma cell disorders affect plasma cells – a type of white blood cell (WBC) produced in the bone marrow.

MGUS is the earliest state of myeloma and is often referred to as a pre-cursor condition. SMM is the intermediate state between MGUS and active myeloma. This InfoWebinar will discuss MGUS, SMM, and research advances in both conditions.

Presented by:
Dr Omar Nadeem
Jerome Lipper Multiple Myeloma Center
Clinical Director, Myeloma Cellular Therapies Program
Dana-Farber Cancer Institute
Instructor in Medicine, Harvard Medical School, Boston, MA

For more information or to register: https://www.myeloma.ca/en/news-events/community-calendar/details/about-mgus-and-smouldering-multiple-myeloma

Wednesday, 14 July 2021 @ 4:00 PM EDT